As we mostly observed inhibition of cell growth rather than pronounced apoptosis, suggesting that PRMT5 may support the metabolic fitness of MNA neuroblastoma, we were intrigued by the consistent PKM2-PKM1 splicing switch observed after PRMT5 inhibition. The gene discussed is PKM; the disease is neuroblastoma.